FOR US HEALTHCARE PROFESSIONALS ONLY
Mary:
Navigating Long-Acting Injectable Conversations to Achieve Longer Dosing Intervals in Adult Patients with Schizophrenia, a virtual national broadcast for pharmacists in mental health. This video was developed from virtual sessions previously recorded in June 2022. Any audience participation and/or interactivity will not be enabled or be available as part of this presentation. Our guest speaker is Dr. Alberto Augsten, pharmacy clinical manager and board-certified clinical toxicologist at Memorial Regional Hospital in Hollywood, Florida.
Dr. Alberto Augsten:
As Mary said, let's go ahead and begin this very interesting discussion on navigating long-acting injectable conversations to achieve longer dosing intervals in adult patients with schizophrenia. So once again, thank you and welcome to the program. It must be stated, this is a promotional educational activity brought to you by Janssen. It's not certified for continued medical education. I'm a paid speaker for Janssen, and we're presenting on behalf of Janssen and must present information in compliance with the FDA.
Now we transition to the discussion of psychoeducation. So, psychoeducation may help address patient's concerns or misconceptions. We know this to be true because many times there's stigmas associated with the use of LAIs. Or perhaps they may have a fear of a needle, right? And those may be barriers. And just something as simple as having a fear of a needle, perhaps offering to say, we can alleviate your pain. We can use a topical numbing agent, perhaps an ice pack after the administration? But really having the psychoeducation to educate them on the benefits of being on the LAI.
Patients won't have to worry about taking a pill for their schizophrenia every day. That's something important to think about. Patients should be given balanced and accurate information about their LAIs. Now, on the bottom you see a dialogue, and I think many of us have had these dialogues. And you see on the left-hand side something that usually is a way you may approach a patient, right? Some of the things to consider. And then saying, I understand you have some concerns about the LAI. If it's okay with you, I'd like to continue our conversation from yesterday—really enforcing that you may have to have more than one conversation, and that's okay. And the patient replying, it's good to see a friendly face—already creating that therapeutic alliance.
I like talking to you. I'm afraid of how the shots might make me feel. And the emphasis on how they might make me feel allows the opening of a discussion on… we could talk about some of the potential side effects, and how we can maybe reduce the risk of said side effects, or address them, or monitor for certain side effects. So that conversation and the psychoeducation is crucial in the offer up.
Back to Top